Since HER2-positivity has been associated with hormone independence due to the absence of expression of hormone receptors and unresponsiveness to tamoxifen (Pietras et al, 1995; Carlomagno et al, 1996), we hypothesised that hormonal risk factors may not influence HER2-positive tumours. This evidence concerns the gene ERBB2 and neoplasm.